120 related articles for article (PubMed ID: 23845224)
1. Hormone receptors and ovarian cancer survival.
Gourley C
Lancet Oncol; 2013 Aug; 14(9):794-5. PubMed ID: 23845224
[No Abstract] [Full Text] [Related]
2. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
4. Five-year survival in patients with endometrioid carcinoma of the ovary versus those with serous carcinoma.
Zwart J; Geisler JP; Geisler HE
Eur J Gynaecol Oncol; 1998; 19(3):225-8. PubMed ID: 9641218
[TBL] [Abstract][Full Text] [Related]
5. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.
Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S
Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients.
Mizuno M; Kajiyama H; Shibata K; Mizuno K; Kawai M; Nagasaka T; Kikkawa F
Br J Cancer; 2015 Apr; 112(8):1376-83. PubMed ID: 25867257
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen-related receptors in ovarian cancer and impact on survival.
Schüler-Toprak S; Weber F; Skrzypczak M; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2555-2567. PubMed ID: 34089362
[TBL] [Abstract][Full Text] [Related]
8. Survival of ovarian cancer in Iran: 2000-2004.
Arab M; Khayamzadeh M; Mohit M; Hosseini M; Anbiaee R; Tabatabaeefar M; Ebrahimi M; Tehranian A; Akbari ME
Asian Pac J Cancer Prev; 2009; 10(4):555-8. PubMed ID: 19827868
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
Scholl SM; Bascou CH; Mosseri V; Olivares R; Magdelenat H; Dorval T; Palangié T; Validire P; Pouillart P; Stanley ER
Br J Cancer; 1994 Feb; 69(2):342-6. PubMed ID: 8297732
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
[TBL] [Abstract][Full Text] [Related]
12. Primary epithelial ovarian carcinoma in Taiwanese women.
Wang PH; Yuan CC; Juang CM; Lai CR; Yen MS; Chao HT; Ng HT
Eur J Gynaecol Oncol; 2001; 22(1):57-60. PubMed ID: 11321496
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
[TBL] [Abstract][Full Text] [Related]
14. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
[TBL] [Abstract][Full Text] [Related]
15. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.
Chen S; Dai X; Gao Y; Shen F; Ding J; Chen Q
Sci Rep; 2017 Dec; 7(1):16922. PubMed ID: 29208958
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma.
Kayikçioglu F; Köse MF; Boran N; Calişkan E; Tulunay G
Int J Gynecol Cancer; 2001; 11(6):466-70. PubMed ID: 11906550
[TBL] [Abstract][Full Text] [Related]
17. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798
[TBL] [Abstract][Full Text] [Related]
19. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
Hefler LA; Grimm C; Ackermann S; Malur S; Radjabi-Rahat AR; Leodolter S; Beckmann MW; Zeillinger R; Koelbl H; Tempfer CB
Cancer Res; 2003 Jun; 63(12):3066-8. PubMed ID: 12810629
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir I; Seidal T
Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
